Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement
IntroductionThe ongoing emergence of SARS-CoV-2 variants poses significant challenges to existing therapeutics. The spike (S) glycoprotein is central to both viral entry and cell-to-cell transmission via syncytia formation, a process that confers resistance to neutralizing antibodies. The mechanisms...
Saved in:
| Main Authors: | Elena Criscuolo, Benedetta Giuliani, Matteo Castelli, Mattia Cavallaro, Sofia Sisti, Roberto Burioni, Davide Ferrari, Nicasio Mancini, Massimo Locatelli, Nicola Clementi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1501200/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01) -
The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells
by: Joel Sop, et al.
Published: (2025-03-01) -
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01) -
Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023
by: Jung Ah Lee, et al.
Published: (2024-11-01) -
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
by: Julia N. Faraone, et al.
Published: (2023-12-01)